API | emodepside

emodepside Report issue

Small molecule Experimental

AACT ChEMBL PubChem

Active Ingredient History

NOW

Emodepside is an anthelmintic drug that is effective against a number of gastrointestinal nematodes, is licensed for use in cats and belongs to the class of drugs known as the octadepsipeptides, a relatively new class of anthelmintic, which are suspected to achieve their anti-parasitic effect by a novel mechanism of action due to their ability to kill nematodes resistant to other anthelmintics. ^Wikipedia

Chemistry

SMILES: CC(C)C[C@@H]1N(C)C(=O)[C@@H](Cc2ccc(cc2)N3CCOCC3)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](Cc4ccc(cc4)N5CCOCC5)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)OC1=O
InChIKey: ZMQMTKVVAMWKNY-YSXLEBCMSA-N
Mol. Mass: 1119.41
ALogP: Missing data
ChEMBL Molecule:
emodepside

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

emodepside

Organizations (5)

Research & Development (5)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (4)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (4)

Filariasis (Phase 1)

Healthy Volunteers (Phase 1)

Hookworm Infections (Phase 2)

Trichuriasis (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 6
# of Trial Organizations: 5

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue